U.K. international orthopedic company Corin Group said it will acquire Omni, a robotic knee surgery platform developer. Raynham, Mass.-based Omni developed its OmniBotics system as an imageless total knee replacement solution which combines a robotic cutting guide with a robotic tool to measure ligament function. The system allows surgeons to tailor the implant position to each […]
OMNIlife Science Inc.
OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]
OmniLife Science launches OmniBotics knee replacement active spacer
Robotic knee surgery platform developer OmniLife Science said today it began testing on its OmniBotics active spacer robotic tissue balancing device at 3 US sites after having won FDA 510(k) clearance in September. The Raynham, Mass.-based company said its OmniBotics active spacer is designed to allow surgeons performing total knee surgeries to quantitatively manage the […]
HART CEO Green bows out | Personnel Moves
Amniox Medical taps ex-Smith & Nephew honcho Dugan for CEO | Personnel Moves
Year in review: CEOs chime in on 2014
As 2014 draws to a close, MassDevice.com asked several medical device company CEOs for their takes on 2014 and what they’re looking for in 2015.
We wanted to get their views on the major trends seen in medtech this year, including the red-hot M&A and IPO scenes, the medical device tax, the regulatory environment in the U.S., and more.
Acelity snares Smith & Nephew exec Agarwal | Personnel Moves
FDA clears juvenile femur replacement that can “grow” with a patient
Stanmore Implants won FDA clearance for an extendible femur implant that can "grow" as the patient does, without the need for surgery, anesthesia or sedation.
The Juvenile Tumour System replaces large portions of the femoral bone in the thigh, which is sometimes removed during cancer treatment.
OMNIlife inks distribution deal with French artificial hip maker
OMNIlife Science Inc. will be the exclusive U.S. distributor of articulation technology used in artificial hips made by a French maker of orthopedic and dental implants.
Taunton, Mass.-based OMNIlife said the deal with Societe d’Etudes Recherches Fabrication-Dedienne Sante will begin as soon as the company receives regulatory approval from the Food & Drug Administration. Further terms of the deal were not announced.
Orthopaedic Synergy sets its sights on French robotic surgery firm Praxim
Orthopaedic Synergy Inc. signed a letter of intent to acquire Praxim SA of France, which makes robotic and computer-assisted surgery devices.
The Taunton, Mass.-based firm, which is the holding company for OMNIlife Science Inc. and Enztec Ltd. of New Zealand, said the deal is aimed at generating shorter product development cycles, according to a press release.
Praxim makes automated systems, software and instruments for total joint arthroplasty procedures. Based in Grenoble, France, the comany also has operations in Santa Clara, Calif., Bethlehem, Pa., Solihull, England, and in the Benelux region, according to its website.